Dexlansoprazole MR-Based Concomitant Quadruple Therapy
Condition: Helicobacter Pylori Infection Interventions: Drug: Dexlan; Drug: Amoxicillin; Drug: Clarithromycin 500mg; Drug: Metronidazole Sponsor: Chang Gung Memorial Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2019 Category: Research Source Type: clinical trials
A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release Capsules
Condition: Healthy Volunteers Interventions: Drug: 30 mg dexlansoprazole capsules manufactured at TOB; Drug: 30 mg dexlansoprazole capsules manufactured at TPC; Drug: 60 mg dexlansoprazole capsules manufactured at TOB; Drug: 60 mg dexlansoprazole capsules manufactured at TPC Sponsor: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2019 Category: Research Source Type: clinical trials